Kommentar
APOL1 and Black Kidney Donors—Reducing Risk or Opportunity?
JAMA Internal Medicine · 01.08.2026 · 186 (8) · 950
DOI: 10.1001/jamainternmed.2026.1004 ↗Kurz gefasst
Kommentar in der Zeitschrift JAMA Internal Medicine, erschienen am 01.08.2026. Verfasst von Adnan Sharif. Beteiligte Einrichtung: Department of Nephrology and Transplantation, Queen Elizabeth Hospital, Birmingham, United Kingdom. Die Arbeit nennt 7 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Nephrology and Transplantation, Queen Elizabeth Hospital, Birmingham, United Kingdom.
- School of Infection, Inflammation and Immunology, University of Birmingham, United Kingdom.
Zitieren
APA
Sharif, A. (2026). APOL1 and Black Kidney Donors—Reducing Risk or Opportunity?. JAMA Internal Medicine, 186(8), 950. https://doi.org/10.1001/jamainternmed.2026.1004
Vancouver
Sharif A. APOL1 and Black Kidney Donors—Reducing Risk or Opportunity?. JAMA Internal Medicine. 2026;186(8):950. doi:10.1001/jamainternmed.2026.1004
BibTeX
@article{Sharif2026,
author = {Sharif, Adnan},
title = {APOL1 and Black Kidney Donors—Reducing Risk or Opportunity?},
journal = {JAMA Internal Medicine},
year = {2026},
volume = {186},
number = {8},
pages = {950},
doi = {10.1001/jamainternmed.2026.1004}
}
EUVIMED